MedTrace Logo

Non-Invasive Reduction of Abdominal Fat

NCT01101997 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-12-21

Study results available
· View outcomes & findings →

Summary

This study is being performed to reduce unwanted abdominal fat using a new applicator for the Zeltiq System.

Conditions

  • Fat Reduction

Interventions

DEVICE

The Zeltiq System

Noninvasive cooling is applied to the treatment area with a defined cooling rate and duration.

Sponsors & Collaborators

  • Zeltiq Aesthetics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-30
Primary Completion
2010-09-28
Completion
2010-12-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01101997 on ClinicalTrials.gov